Medtronic (MDT) Stock Price, News & Analysis

Company Overview

Medtronic plc (NYSE: MDT) is a global leader in medical technology, dedicated to developing innovative therapies that improve the health and lives of millions of people around the world. The company specializes in devices and solutions across a broad spectrum of medical specialties, including cardiac rhythm management, diabetes management, restorative therapies, minimally invasive therapies, and surgical technologies. Medtronic’s offerings are designed to address chronic diseases and complex medical conditions, enabling healthcare providers to deliver more effective patient care.

Medtronic’s product portfolio includes implantable cardiac pacemakers, defibrillators, heart valves and stents, insulin pumps and continuous glucose monitoring systems, and neurological and spinal therapies. The company also provides advanced surgical instruments and robotic-assisted surgical platforms, as well as ENT and respiratory care solutions. By integrating digital health tools and data analytics, Medtronic aims to enhance procedural efficiency, improve patient outcomes and reduce the overall cost of care.

With operations in more than 150 countries, Medtronic maintains a diverse geographic presence, serving hospitals, clinics and surgical centers across the Americas, Europe, Asia, Africa and Australia. The company invests heavily in research and development, operating multiple R&D centers worldwide to foster collaboration with physicians, academic institutions and research organizations. This global footprint enables Medtronic to tailor its products to meet regional healthcare needs while remaining at the forefront of medical innovation.

Founded in 1949 by Earl Bakken and Palmer Hermundslie in Minneapolis, Medtronic has grown from a small medical equipment repair shop into one of the largest medtech companies in the world. Headquartered in Ireland with principal executive offices in the United States, Medtronic is led by Chairman and CEO Geoff Martha. Under his leadership, the company continues to pursue strategic acquisitions and partnerships, reinforcing its commitment to advancing the treatment of chronic diseases and improving patient quality of life.

Key Stats

• Today's Range: $86.71 to $88.75
• 50-Day Range: $80.70 to $88.47
• 52-Week Range: $75.96 to $96.25
• Volume: 10.09 million shs
• Average Volume: 6.98 million shs
• Market Capitalization: $113.74 billion
• P/E Ratio: 24.50
• Dividend Yield: 3.20%
• Price Target: $97.87
• Consensus Rating: Moderate Buy

Medtronic Stock Analysis - MarketRank™

Medtronic scored higher than 97% of companies evaluated by MarketBeat, and ranked 34th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 8 buy ratings, 9 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Medtronic has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.78%

Earnings Growth

Earnings for Medtronic are expected to grow by 6.78% in the coming year, from $5.46 to $5.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medtronic is 24.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medtronic is 24.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.43.

Price to Earnings Growth Ratio

Medtronic has a PEG Ratio of 2.32. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Medtronic has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.66% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently increased by 7.49%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Medtronic pays a meaningful dividend of 3.30%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Medtronic has been increasing its dividend for 49 years.

Dividend Coverage

The dividend payout ratio of Medtronic is 78.45%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Medtronic will have a dividend payout ratio of 48.71% next year. This indicates that Medtronic will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -1.26

Percentage of Shares Shorted

0.66% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently increased by 7.49%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.34

News Sentiment

Medtronic has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 63 news articles for Medtronic this week, compared to 36 articles on an average week.

Search Interest

Only 48 people have searched for MDT on MarketBeat in the last 30 days. This is a decrease of -2% compared to the previous 30 days.

MarketBeat Follows

Only 25 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medtronic insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.20% of the stock of Medtronic is held by insiders.

Percentage Held by Institutions

82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MDT Stock Analysis - Frequently Asked Questions

How have MDT shares performed this year?

Medtronic's stock was trading at $79.88 at the beginning of the year. Since then, MDT stock has increased by 10.9% and is now trading at $88.6210.
View the best growth stocks for 2025 here.

How were Medtronic's earnings last quarter?

Medtronic PLC (NYSE:MDT) issued its quarterly earnings data on Wednesday, May, 21st. The medical technology company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.58 by $0.04. The business's revenue was up 3.9% on a year-over-year basis.
Read the conference call transcript.

Who are Medtronic's major shareholders?

Medtronic's top institutional shareholders include Cullen Investment Group LTD. (0.01%), Rowlandmiller & PARTNERS.ADV and Kera Capital Partners Inc.. Insiders that own company stock include Geoffrey Martha, Sean Salmon, Gregory L Smith, Hoedt Rob Ten, Brett A Wall and Michael Marinaro.
View institutional ownership trends.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medtronic investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Meta Platforms (META), NVIDIA (NVDA), Chevron (CVX), Verizon Communications (VZ) and Broadcom (AVGO).

Company Calendar

• Record date for 4/11 Dividend: 3/28/2025
• Ex-Dividend for 4/11 Dividend: 3/28/2025
• Dividend Payable: 4/11/2025
• Last Earnings: 5/21/2025
• Record date for 7/11 Dividend: 6/27/2025
• Ex-Dividend for 7/11 Dividend: 6/27/2025
• Today: 7/01/2025
• Dividend Payable: 7/11/2025
• Next Earnings (Estimated): 8/19/2025
• Fiscal Year End: 4/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:MDT
• CIK: 1613103
• Web: www.medtronic.com
• Phone: (531) 438-1700
• Fax: 763-514-4879
• Employees: 95,000
• Year Founded: 1949

Price Target and Rating

• Average Stock Price Target: $97.87
• High Stock Price Target: $110.00
• Low Stock Price Target: $87.00
• Potential Upside/Downside: +11.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.63
• Research Coverage: 19 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.62
• Trailing P/E Ratio: 24.31
• Forward P/E Ratio: 16.13
• P/E Growth: 2.32
• Net Income: $4.66 billion
• Net Margins: 13.90%
• Pretax Margin: 16.78%
• Return on Equity: 14.54%
• Return on Assets: 7.83%

Debt

• Debt-to-Equity Ratio: 0.53
• Current Ratio: 1.85
• Quick Ratio: 1.42

Sales & Book Value

• Annual Sales: $33.54 billion
• Price / Sales: 3.37
• Cash Flow: $7.94 per share
• Price / Cash Flow: 11.10
• Book Value: $37.62 per share
• Price / Book: 2.34

Miscellaneous

• Outstanding Shares: 1,282,540,000
• Free Float: 1,279,978,000
• Market Cap: $112.99 billion
• Optionable: Optionable
• Beta: 0.79